AEAhmed Elmewafy

Ahmed Elmewafy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmed Elmewafy has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex Differences in Cardiac Rehabilitation Access and Utilization: A Systematic Review of Barriers and Facilitators in Cardiovascular Care

    by Priyanth Alaguraja, Ahmed T. Elmewafy, Ibrahim Antoun

    Cardiac rehabilitation (CR) is central to secondary prevention, but women remain less likely than men to access and fully utilize CR. This systematic review examined sex differences across the CR utilization continuum, separating referral, enrollment, attendance or session exposure, and program completion, and evaluated barriers and facilitators at each stage. PubMed was searched for studies published from January 1, 2000 through March 2025 reporting sex‐specific CR utilization outcomes. Supplementary citation searching was undertaken to improve completeness. Outcomes were classified as referral, enrollment, attendance or session exposure, and completion or dropout. Forty‐six unique study cohorts, including over one million patients, met the inclusion criteria. Women were most consistently disadvantaged at referral and initial access. In several cohorts, sex differences narrowed after referral or after adjustment for clinical, psychosocial, and structural factors. A large multicentre referral‐strategy cohort reported lower overall referral (57.8% vs. 67.2%) and enrollment (49.3% vs. 58.6%) in women than men, but among referred patients, subsequent enrollment was similar (82% vs. 85%). Across studies, transport, caregiving, comorbidity, financial constraints, and lower CR awareness disproportionately affected women, while work and time conflicts were more prominent among men. The largest completion analysis ( n = 5922) found that sex was not an independent predictor of withdrawal after adjustment (OR 0.89, 95% CI 0.76–1.05). Automatic or systematic referral, liaison‐supported referral, geographic matching to nearer programs, flexible delivery models, and targeted navigation were identified as facilitators of access and utilization. Sex disparities in CR are stage‐specific rather than a single “adherence” phenomenon. The strongest and most consistent gap occurs at referral and initial access, while differences may narrow once patients are referred or when systematic referral pathways are used. Equity‐focused CR services should combine system‐level referral strategies with interventions addressing transport, caregiving, comorbidity, financial, and program‐fit barriers.

  • Open Access

    Prognostic Value of Heart‐Type Fatty Acid‐Binding Protein in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis

    by Ahmed Elmewafy, Eyad Jamileh, Abdullah Hussain, Loay Kamel, Omar Farooq, Hany Gamal, Ibrahim Antoun

    Introduction: Heart‐type fatty acid‐binding protein (H‐FABP) is rapidly released following myocardial injury, but its prognostic significance in acute coronary syndrome (ACS) remains uncertain. We evaluated the association between elevated H‐FABP and adverse clinical outcomes in confirmed or suspected ACS. Methods: PubMed, Embase, CENTRAL, Web of Science and Scopus were searched from inception to 30 August 2026 without date restriction. Studies assessing diagnostic and/or prognostic relevance of circulating H‐FABP in adults with confirmed or suspected ACS were eligible. Prognostic outcomes included all‐cause mortality, major adverse cardiovascular events (MACE), heart failure (HF)–related hospitalisation and recurrent myocardial infarction (MI). Risk of bias was assessed using QUIPS. Crude odds ratios (ORs) from extractable 2 × 2 event data were pooled using inverse‐variance random‐effects models with restricted maximum‐likelihood estimation. Results: Twelve studies were included, with five contributing to meta‐analysis. Elevated H‐FABP was associated with higher odds of all‐cause mortality (OR 5.68; 95% CI 3.98–8.09; I 2 = 30 % ), MACE (OR 4.56; 95% CI 1.97–10.55; I 2 = 47 % ), HF‐related hospitalisation (OR 4.29; 95% CI 2.94–6.26; I 2 = 0 % ) and recurrent MI (OR 1.65; 95% CI 1.15–2.37; I 2 = 0 % ). Pooled estimates were unadjusted; seven studies were synthesised narratively. Conclusion: Elevated H‐FABP is associated with adverse outcomes in ACS, but current evidence does not establish independent prognostic value. Further prospective studies should determine whether H‐FABP adds predictive value beyond established clinical and biochemical risk markers.

  • Open Access

    Artificial Intelligence for the Diagnosis of Transthyretin Amyloid Cardiomyopathy: A Systematic Review of Machine Learning Application

    by Eyad Jamileh, Ahmed T. Elmewafy, Muhammad Abdullah Qadeer, Zuhaib Zulfiqar, Kiran Kang, Kaveh Hosseini, Ibrahim Antoun

    Background: Transthyretin amyloid cardiomyopathy (ATTR‐CM) remains under‐recognised, and earlier identification is increasingly important with disease‐modifying therapy. Artificial intelligence (AI) applied to routine cardiovascular data may support screening, triage and diagnostic interpretation. Methods: MEDLINE, Embase, CINAHL, Web of Science and CENTRAL were searched from inception to August 2026 for studies evaluating AI/machine learning for ATTR‐CM detection, screening or classification, including broader cardiac‐amyloidosis models with separately extractable ATTR‐specific performance and models detecting imaging phenotypes relevant to ATTR‐CM screening. Risk of bias was assessed using an adapted QUADAS‐2 framework, with AI‐specific considerations informed by QUADAS‐AI development work; selected TRIPOD + AI and CLAIM domains were assessed descriptively. Owing to substantial clinical and methodological heterogeneity, meta‐analysis was not performed. Results: Twenty‐eight primary reports were included, representing > 120,000 report‐level participant entries, although overlapping cohorts precluded estimation of a unique‐patient total. Performance varied by modality and task. AUCs ranged approximately 0.55–0.97 for ECG‐containing models, 0.72–1.00 for echocardiography/POCUS and 0.70–0.85 for CT‐based single‐modality approaches; CMR differentiation of ATTR from AL achieved an AUC of 0.92. Nuclear‐imaging models often showed high discrimination, including external‐testing AUCs of 0.925–1.000, although several targeted tracer‐uptake phenotypes rather than definitive ATTR‐CM. Recurrent concerns included enriched populations, limited event counts, internal‐only testing, threshold optimisation and incomplete calibration reporting. Conclusions: AI shows promise for ATTR‐CM screening and automated interpretation, but reported discrimination should not be equated with real‐world clinical performance. Prospective multicentre validation, calibration at realistic prevalence, transparent reporting and workflow‐level evaluation are required before routine implementation.

  • Open Access

    Comparative Outcomes of Rotational Versus Orbital Atherectomy in Calcified Coronary Lesions: An Updated Systematic Review and Meta‐Analysis

    by Eyad Jamileh, Ahmed Elmewafy, Fahad Muhammad, Ahmed Ali Kayyale, Usama Al Bushe Ade, Abdelmadjid Zinet, Umar Faruq Ali, Ibrahim Antoun

    Introduction: Severe coronary artery calcification (CAC) can complicate percutaneous coronary intervention (PCI) and is associated with less favourable procedural and clinical outcomes. Rotational atherectomy (RA) and orbital atherectomy (OA) are established calcium‐modification strategies used to facilitate PCI in heavily calcified lesions. This systematic review and meta‐analysis evaluated the comparative clinical and procedural outcomes of RA and OA in patients with severe CAC. Methods: This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidance. PubMed, EMBASE, and CENTRAL were searched from inception to July 2026 for studies directly comparing RA and OA in patients undergoing PCI for severe CAC. Eligible studies were synthesised quantitatively where appropriate and narratively otherwise. Risk of bias was evaluated using the Newcastle–Ottawa Scale for observational studies and the Cochrane Risk of Bias 2 tool for the randomised controlled trial. Results: No statistically significant differences between RA and OA were identified for short‐term major adverse cardiovascular events (MACE), short‐ or long‐term all‐cause mortality, cardiac mortality, long‐term nonfatal myocardial infarction (MI) or short‐term target vessel revascularisation (TVR). Compared with OA, RA was associated with higher odds of long‐term MACE (OR 1.51, 95% CI 1.01–2.26), short‐term nonfatal MI (OR 1.77, 95% CI 1.05–2.98) and long‐term TVR (OR 2.51, 95% CI 1.12–5.64). Conversely, coronary dissection occurred less frequently with RA (OR 0.38, 95% CI 0.20–0.72). There were no significant between‐group differences in cardiac tamponade, device‐induced coronary perforation, slow‐flow/no‐reflow, fluoroscopy time or contrast volume. Conclusion: In this updated meta‐analysis of more than 80,000 patients, OA was associated with lower pooled rates of long‐term MACE, short‐term nonfatal MI and long‐term TVR, whereas RA was associated with a lower rate of coronary dissection. No consistent difference in all‐cause mortality was demonstrated. Given the predominantly observational evidence base, these associations should not be interpreted as evidence of causal superiority, and device selection should remain individualised according to lesion characteristics, intravascular imaging findings and operator expertise.


  • Open Access

    Reclassification of Hypophosphatemic Bone Disease as X-Linked Hypophosphatemia Following Genetic Testing in Adulthood

    by Loay Kamel, Abdullah Hussain, Ahmed Elmewafy, Dalal S. Ali, Aliya A. Khan